Please note: Nova Scotia Drugs and Therapeutics Committee Receipt and Review of Submissions
Submissions for interchangeability consideration must be sent through a secure file transfer site. To access the secure site, manufacturers should contact email@example.com
Manufacturers will be sent a link to the secure site to submit documents. After a manufacturer has submitted through the secure site once, all additional submissions can be made the same way, using the same link.
The Nova Scotia Drugs and Therapeutics Committee, representing the professions of Medicine, Dentistry, and Pharmacy, is responsible for determining interchangeability among pharmaceutical products and for recommending to the Department of Health and Wellness those products which will appear as interchangeable in the Nova Scotia Formulary.
Pharmaceutical products are considered for interchangeability only when they are the subject of a formal submission which complies with the Nova Scotia Criteria for Interchangeability. This document includes the guidelines for interchangeability, a description of the review process, and the requirements for formal submissions with both submission forms and letter templates.
The next regular meeting of the Drugs and Therapeutics Committee is scheduled for:
28 February 2024